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Abstract
According to toxicity of various types of cancer treatments on different kind of cells with high division activities such as germ cells, antioxidants may 
protect these cells in testes against the toxic effects of the chemotherapeutic drugs. For this purpose, 24 h after busulfan treatment, 30 adult male 
wistar-rats were divided to six groups. Intra-peritoneally administrations of normal saline in control group and DMSO (as a busulfan solvent) in DMSO 
group were performed daily for 6 weeks beside the treatment contain vitamin E (Vit-E group), L-carnitine and melatonin (LM group), atorvastatin and 
melatonin (AM group), atorvastatin, L-carnitine, and melatonin (ALM group). After decapitation and removal of the testes, molecular evaluations were 
performed by the relative abundance measurement of DAZL, Bcl2, and Casp3 transcripts. The results of this study exhibited high level of expression 
of DAZL in Vit-E treated rats compared to control counterparts (P<0.01). The expression level of Bcl2 is significantly down-regulated in LM (P<0.008), 
and ALM groups (P<0.001), and the relative abundance of Casp3 transcripts was significantly lower in AM (P<0.001) and ALM (P<0.007) than that of 
control group. As well as, there was significant high expression of this gene in Vit E-treated rats compared to the rats of control group. In conclusion, 
busulfan destructive effects were moderated with Vit-E administration through regulation of the expression of DAZL. The other antioxidants used in 
different combinations had not amelioration effects on spermatogenesis in busulfan-induced male rats, though the positive effects of some of these 
antioxidants on apoptosis reduction.
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Erkek Rat Testislerinde Busulfan Kaynaklı Hasara Karşı Vitamin 
E, Melatonin, L-karnitin ve Atorvastatin’in Koruyucu Etkisi: Gen 
Ekspresyonunun Değerlendirilmesi
Öz
Çeşitli kanser ilaçlarının toksisitelerine bağlı olarak eşey hücreleri gibi yüksek bölünme kapasitesine sahip çeşitli hücrelerde meydana gelen hasara 
karşı antioksidanlar koruyucu olabilir ve bu durum testis dokusunda kemoterapötik ilaçlarla oluşan hasarda etkili olabilir. Bu amaçla, 24 saat busulfan 
uygulaması sonucunda 30 ergin erkek Wistar rat altı gruba ayrıldı. İntraperitoneal olarak 6 hafta süresince DMSO grubuna fizyolojik tuzlu su ve 
DMSO (busulfan çözücüsü olarak) uygulandı. Diğer gruplarda busulfan uygulamasına ilave olarak E (Vit-E grubu), L-karnitin ve melatonin (LM grubu), 
atorvastatin ve melatonin (AM grubu), atorvastatin, L-karnitin ve melatonin (ALM grubu) uygulamaları gerçekleştirildi. Hayvanlarda dekapitasyonu 
takiben testis dokuları alındı ve DAZL, Bcl2, ve Casp3 miktarları karşılaştırmalı olarak moleküler açıdan değerlendirildi. Çalışma sonucu, Vit-E uygulanan 
ratlarda DAZL ekspresyonunun kontrol grubuna oranla daha fazla olduğu gözlemlendi (P<0.01). LM (P<0.008) ve ALM (P<0.001) gruplarında Bcl2 
ekspresyonu aşağı yönde regule edilirken, AM (P<0.001) ve ALM (P<0.007) gruplarında Casp3 ekspresyonu anlamlı derecede control grubuna oranla 
daha azdı. Kontrol ile karşılaştırıldığında Vit-E uygulanan grupta Casp3 ekspresyonunun anlamlı derecede yüksek olduğu belirlendi. Sonuç olarak, 
busulfan kaynaklı hasarın Vit-E uygulaması sonucu DAZL ekspresyonu yolu ile normalize edildiği tespit edildi. Busulfan ile erkek ratlarda spermatogenez 
üzerine oluşturulan hasara karşı çalışmada uygulanan diğer antioksidanların hasarı azaltmada etkili olmadığı ancak bazılarının apoptozis üzerine 
etkisinin olduğu belirlendi.
Anahtar sözcükler: Rat, Busulfan, Vitamin E, Melatonin, L-karnitin, Atorvastatin, DAZL, Bcl2, Casp3
 İletişim (Correspondence)
 +98 917 7323202
 kadivar.ali@sku.ac.ir
Kafkas Universitesi Veteriner Fakultesi Dergisi
ISSN: 1300-6045 e-ISSN: 1309-2251
Journal Home-Page: http://vetdergikafkas.org
Online Submission: http://submit.vetdergikafkas.org
Research Article
A
r
ti
c
le
 in
 P
r
es
s
Kafkas Univ Vet Fak Derg
x (x): xxx-xxx, 2019
DOI: 10.9775/kvfd.2019.21726
2
Amelioration Effects of Vitamin E ...
INTRODUCTION
Alkylating agents as chemotherapeutic drugs are often used 
to treat cancer and increase the survival rates of patients. 
Alkylating agents, affect cell division by adhesion to one 
strands of the DNA [1]. Therefore, cells or tissues with high 
division activities such as germ cells and testes are more 
susceptible to these agents’ side effects. Spermato-genesis 
makes round haploid spermatids through the reductive 
divisions of meiosis [2]. It is clear that certain chemo- 
therapeutic drugs specially alkylating agents influence 
spermatogenesis at least temporarily and in some cases 
permanently. Single doses of busulfan as an alkylating 
agent can permanently sterilize rats at non-lethal doses 
and cause long-term morphological damage to sperm 
produced by surviving spermatogonia [3]. Busulfan toxicity 
occurs by several different mechanisms, including reactive 
oxygen species (ROS) formation and protein damage 
(oxidation) [4]. ROS are directly involved in precarious 
oxidative damage of cellular macromolecules such as 
proteins and nucleic acids in germ cells, which can lead 
to cell death [5]. Indeed, the overproduction of ROS and 
the consequent oxidative stress has a critical role in 
inhibition of development of germ cells. Forasmuch as, 
the rats treated with Busulfan exhibited a defined increase 
in apoptosis,  using cytoprotective and anti-apoptotic 
agents such as antioxidants can neutralize both ROS and 
apoptosis procedure caused by them [6]. ROS are scavenged 
by some antioxidants such as L-carnitine, Vitamin E 
(α-tocopherol), and Atorvastatin via their interfering with 
the lipid peroxidation chain reaction. Another small 
molecule antioxidant, Melatonin, which can detoxify highly 
reactive hydroxyl free radicals (OH) is involved in the 
detoxification of free radicals [7]. Co-administration of these 
components also change produced ROS profile, prevented 
lipid peroxidation and improved antioxidant status, 
synergistically [8].  Therefore, strategies that effectively 
preserve fertility during the course of cancer treatment 
especially through the decrease in apoptosis should be 
developed. 
In this study all mentioned antioxidants, singly or in 
different combinations, were used to amelioration 
busulfan side effects in treated male rats  and then the 
expression amount of deleted in azoospermia-like (DAZL) 
as a gene related to spermatogenesis resumption and 
B-cell lymphoma 2 (Bcl2) and Caspase 3 (Casp3) as the 
genes related to apoptosis was measured.  
DAZL is a gene cluster which gets deletions in at least 10% of 
males with oligozoospermia or azoospermia [9].This gene is 
a DAZ autosomal homologue. As a result, DAZL has always 
been seen as a promising candidate for male infertility. DAZL 
plays an important role in the spermatogenic processes. 
Bcl2 gene is an anti-apoptotic member of Bcl2 Family, 
regulators of the cellular life-or-death switch, that prevents 
cytochrome C release, and hence caspase-9 activation and 
subsequently several other caspases, independently of 
mitochondrial damage [10]. Besides, caspase-3 is a cysteine 
protease that is activated early in a sequence of events 
associated with apoptosis [11].  
The aim of the present study was reduction the amount 
of apoptosis and subsequently improves the spermato-
genesis and preserves fertility of azoospermic animal model 
using busulfan in rat, with a focus on related molecular 
pathways.
MATERIAL and METHODS
Animals
Thirty adult male wistar-Rats (2-3 months old and 200-250 
g) were purchased from Faculty of Veterinary Medicine of 
Shahrekord University and were housed for 2 weeks at 
the animal lab of Veterinary Clinic under the Standard 
laboratory conditions (12 h dark and 12 h light cycle, 
temperature of 23±3°C, and 50±5% humidity) for adaptability 
of rats to new living environment. Animal cages were 
kept clean, and commercial food (pellet) and water were 
provided ad libitum.
Experimental Design
In total, all rats were treated with two doses of 25 and 10 
mg/kg busulfan with 14 days interval and after 24 h were 
randomly assigned to the following groups: Sham group 
that treated with DMSO as busulfan solvent, treated with 
busulfan (control group), and treatment groups including: 
treated with 100 mg/kg vitamin E (Vit E group), treated with 
100 mg/kg L-carnitine and 1 mg/kg melatonin (LM group), 
treated with 20 mg/kg atorvastatin and 1 mg/kg melatonin 
(AM group), treated with 20 mg/kg atorvastatin, 100 mg/
kg L-carnitine, and 1 mg/kg Melatonin (ALM group). Each 
group assigned by 5 rats. In all groups all administrations 
were performed intra-peritoneally daily for 6 weeks. 
Busulfan dose was assigned based on previous studies 
that established the toxic effect of busulfan on rat testes [12]. 
The atorvastatin [13], L-carnitine [13], melatonin [14] and Vit 
E [15] doses were also selected based on previous reports 
demonstrating their anti-oxidative effect. This study was 
approved by the Institutional Ethics Committee for Animal 
Experimentation and was conducted in accordance with 
the international guidelines [16]. 
Organ Removal and Tissue Processing
Animals were killed by decapitation under ether anesthesia, 
and testes of the animals were removed. One testis was 
used for sperm collection and the other one was preserved 
in -80ºC freezer until molecular evaluations. 
Sperm Collection and Evaluation
Sperm was collected from tail of left epididymis for all the 
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experimental rats. The left epididymis was immediately 
minced with scalpels and placed in pre-warmed microtube, 
containing 1 mL of Human Tubal Fluid (HTF) medium 
without BSA and placed in a 37°C incubator for 10 min. For 
sperm counting, 50 µL of the solution was diluted 10 times 
with 0.9% saline and a drop was transferred into chamber 
of Neubauer hemocytometer. Sperm counted under a 
standard optical microscope in order to determine the 
number of spermatozoa.
After 10 min of incubation, sperm motility was assessed by 
putting one drop of the on a warmed microscope slide. A 
cover slip was placed and at least 5 microscopic fields was 
observed at 400-fold magnifications. The percentage of 
nonmotile sperm was recorded for each rat. 
Sperm viability was assessed with eosin–nigrosin staining. 
For this, 10 µL of sperm suspension were mixed with equal 
volume of eosin-nigrosin on a warmed microscope slide 
and a thin smear was prepared. Samples were observed 
under light microscope at a magnification of 1000×. At 
least 100 sperm were evaluated to discriminate death 
sperm (red stained) of live (not stained).
Molecular Evaluation
Total RNA Extraction, DNAase Treatment and cDNA 
Synthesis: To extract total RNA, tissues of testes (100 mg) 
were mechanical fragmented with a scalpel. Half mL RNX-
PLUS solution (Sinaclon Bioscience, Karaj, Iran) containing 
phenol and guanidine was added and placed at room 
temperature for 5 min to homogenized samples. After 
adding 120 µL chloroform, the mixture was centrifuged 
at 8.000 g and 4ºC for 5 min. The upper aqueous phase 
of supernatant was separated, and after addition of 400 
µL isopropanol (100%), it was centrifuged (8000 g, 4°C, 5 
min) and the RNA pellet was washed with 80% ethanol. 
Upon centrifugation at the same condition, the pellet was 
suspended in DEPC-treated water. To remove genomic DNA 
contamination, the extracted RNA was treated by RNase-
free DNase I and its buffer (Sinaclon Bioscience, Karaj, 
Iran) and incubated at 37°C for 30 min. The reaction was 
stopped by EDTA at 65°C for 10 min, and the amount and 
quality of RNA were determined by spectrophotometry 
(Micro-volume Spectrophotometer System, Nano Mabna 
Iranian, Tehran, Iran). Only RNA of sufficient purity, having 
an absorbance ratio (A260/280) between 1.8 and 2.2 was 
considered for synthesis of cDNA.
Shortly after extraction, total RNA (1 μg) was reversely 
transcribed into cDNA (less than 2h) in a 5 µL reaction 
volume using the Easy cDNA synthesis kit, offered by the 
manufacturer (Pars tous biotechnology, Mashhad, Iran). 
The thermal program for cDNA synthesis included the 
following 3 steps: 25°C for 10 min (activation of the reverse 
transcriptase), 47°C for 60 min (reverse transcription), and 
85°C for 5 min (inactivation of the reverse transcriptase). 
The synthesized cDNA was then stored at -20°C. 
Quantitative Real-Time PCR: Real-time PCR was performed 
in two replicates for each sample (Rotor Gene Q 6000, 
Qiagen, USA). Primer sequences, the GenBank accession 
numbers, the size of amplified products, and annealing 
temperature of each primer are shown in Table 1. Half µL 
DNase I treated cDNA was added to 5 µL SYBR Premix Ex 
Taq II Mix and 0.5 µM of each specific primer in a total 
volume of 10 µL. The PCR program was comprised of 45 
cycles of 94°C for 5s (denaturation), and 54-60°C for 30 s 
(annealing & extension; Table 1) and 72°C for 30 s. 
Considering the selection of an appropriate housekeeping 
gene as a reference gene for normalization, there are 
several studies demonstrating that Actb is highly reliable 
reference genes among the other genes used for RT-qPCR 
normalization and analysis of relative gene expression in 
the mouse testes [17].
Melt curve analysis was conducted to confirm the 
specificity of each product. The no-template control and 
no-reverse transcriptase control were considered to check 
contamination of the PCR reagents. Data were analyzed 
using LinReg PCR software version 2012.0 (USA), to give 
the threshold cycle number (Ct). Mean efficiency values (E) 
for each gene were also determined from the amplification 
profiles of individual samples using the same software [7]. 
The following formula was applied to determine the 
relative gene expression in tissue testes of treated rat 
compared to the control group [18,19]. 
Statistical Analysis
The differences in relative abundance of gene expression 
Table 1. Sequence and annealing temperature of primers used for Real Time-PCR
Gene
Gene Bank
Accession No.
Primer Sequence (5’-3’)
Product
Size (bp)
Annealing 
Temp (°C)
Reference
Casp3 NM_012922.2 F-GGACCTGTGGACCTGAAAAAR-GCATGCCATATCATCGTCAG 159 54
[20]
Bcl2 NM_016993.1 F-GGTGAACTGGGGGAGGATTGR-GCATGCTGGGGCCATATAGT 197 60
[20]
DAZL NM_001109414.1 F-TCTTCATCAGCAACCACCAGR-GACAAATCCATAGCCCTTCG 195 60
[12]
Β-Actin (Actb) NM_031144.3 F- CACCCGCGAGTACAACCTTCR- GAAGCCGGCCTTGCACAT 127 60
Designed by 
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between groups were analyzed using one sample t-test 
student after ArcSin transformation with SPSS software 
version 20.0.0 (IBM Corp.; USA). Data were expressed as 
mean±SEM. Differences were considered significant at 
P<0.05. 
RESULTS
The results of sperm evaluation showed that the mean 
percent of live and non-motile sperm and the sperm 
concentration were not different significantly between 
treatment groups. The difference was only significant 
between control and sham for all three parameters 
(Table 2). 
The results of gene expression were presented by relative 
comparison of all of treatments groups with control group. 
The relative abundance (RA) of transcripts in tissue of 
treated rat testes has been shown in Fig. 1A-B and Fig. 2. As 
shown in Fig. 1A, the expression level of Bcl2 is significantly 
down regulated in those rats received both L-carnitine 
and melatonin (LM) (P<0.008), and those that received all 
three antioxidants, Atorvastatin, L-carnitine and melatonin 
(ALM) (P<0.001) in comparison with control group. No 
significant difference was observed between each of other 
treatment groups and control group in Bcl2 expression. 
According to Fig. 1B, the relative abundance of Casp3 
transcripts was significantly lower in AM (P<0.001) and 
ALM (P<0.007) than control group. As well as, there was 
significant high expression of this gene in Vit E-treated 
rats compared to the rats of control group. There was 
no significant difference between each of other groups 
(DMSO, and LM) and control group.
Table 2. The mean±SE percent of live and non-motile sperm and the sperm concentration
Sperm Characteristics in Treatment Groups N Mean
95% Confidence Interval for Mean
Lower  Bound Upper Bound
Live sperm (%)
Sham 8 67±1.52a 63.40 70.60
ALM 8 52±1.92ab 47.46 56.54
vitamin E 8 50.25±2.6ab 44.09 56.41
Control 8 24.75±2.23b 19.47 30.03
Total 32 48.5±2.9 42.58 54.42
Sperm count
Sham 8 564.38±15.63a 527.40 601.35
ALM 8 461.63±18.78ab 417.21 506.04
vitamin E 8 424.38±11.7ab 389.93 458.82
Control 8 225±23.28b 197.35 252.65
Total 32 418.84±131.72 371.35 466.34
Non-motile sperm
Sham 8 18.88±1.31a 15.76 21.99
ALM 8 28±1.45ab 24.57 31.43
vitamin E 8 31.13±1.7ab 27.09 35.16
Control 8 34.5±3.15b 27.05 41.95
Total 32 28.13±1.42 25.22 31.03
ALM: atorvastatin, L-carnitine, and melatonin group, Sham: treated with DMSO as busulfan solvent
Fig 1. Relative abundance of Bcl2 (A) and Casp3 (B) transcripts in rat testes tissue derived from treated rats with busulfan solvent (DMSO), Vitamin 
E (Vit E), L-carnitine and Melatonin (LM), atorvastatin and melatonin (AM), atorvastatin, L-carnitine, and Melatonin (ALM) compared to control 
group (busulfun treated rats).  All reactions were normalized for β-Actin mRNA expression. Values with superscripts “*” refers to significant (P<0.05) 
differences in relative transcript abundance of each group compared to control group
5Deleted in azoospermia-like, exhibited high level of 
expression in Vit E treated rats compared to control 
counterparts (P<0.01) and no differences were found 
between each of other treatment groups (DMSO, AM, LM, 
and ALM) and control group (Fig. 2).
The relative abundance of Bcl2, Casp3, and DAZL transcripts 
in rat testes tissue derived from treated rats in all treatment 
groups compared to control group (Busulfun treated rats) 
are briefly shown in Table 3.
DISCUSSION
One of the most important problems in the life of couples’ 
is infertility and it’s complications and the causes of some 
infertilities are related to men. The most common cause of 
male infertility is inability to produce sufficient numbers 
of active and healthy sperms [21].  Many factors can affect 
sperm production and infertility risks. Among these factors 
are using chemotherapy drugs for cancer, antibiotics, 
toxic substances, s, stress, pesticides, radiation, vitamin 
deficiency, and air pollution. These factors can reduce 
sperm concentration with generation of free radicals and 
oxidation of germ cells in the testes [21].
Busulfan, as a chemotherapy drug, is a bifunctional 
alkylating agent and is used for the treatment of various 
malignant diseases, such as polycythemia vera and chronic 
myelogenous leukemia [3]. Busulfan is a highly cytotoxic 
and genotoxic agent [3] that can induce various adverse 
effects, both acute and chronic, such as DNA damage 
and subsequently activates apoptosis or senescence in a 
cell type-dependent manner probably due to oxidative 
stress [4] in several biological organs such as hematologic [22], 
nervous [23] and reproductive organs [24]. It has been 
conﬁrmed that chemotherapy with busulfan can induce 
apoptosis in sperm [6] and increase ROS generation and 
resulting in death of spermatozoa [25]. As well as, accurance 
of teratospermia, the presence of spermatozoa with 
abnormal morphology in semen is the other possible result 
of busulfan treatment in mice [3]. These studies showed 
that busulfan is involved in the arrest of spermatogenesis, 
though some of the changes are reversible and dose 
dependent. In this study two dose of 25 and 10 mg/
kg busulfan with 14 days interval were used which can 
destruct the spermatogenic process in rat as was shown in 
other studies [3,26,27]. 
Antioxidants neutralize free radicals and subsequently the 
oxidative reactions caused by them. The dietary antioxidants 
may be beneﬁcial in reducing the lipid peroxidation and 
DNA damage in sperm during the treatment with busulfan [28]. 
Different antioxidants have examined in challenging 
procedures to reduce the adverse effects of ROS on rat 
spermatozoa [16,29].
Here, we studied the protective effect of vitamin E, 
melatonin, L-carnitine, and atorvastatin treatment, alone 
and in different combinations, against busulfan-mediated 
sperm damage in mice. Our results demonstrated that 
perform all treatments 48h hours after the beginning of 
chemotherapy with busulfan and daily administration 
of antioxidants for 8 weeks can slightly reduce busulfan-
mediated destructions.
To confirm the role of busulfan in germ cells destruction 
and apoptosis, respectively, DAZL activation and anti-
apoptotic molecule Bcl2 as well as activation of Casp3 were 
measured in testes tissue after busulfan treatment. 
Consistent with busulfan-induced increased mitochondrial 
membrane depolarization, significantly increased expression 
of Bcl2, was observed in testes tissue treated with vitamin 
E compared to other antioxidants-treated rats, suggesting 
busulfan-induced apoptosis is moderated with Vitamin 
E administration through regulation of the expression of 
Bcl2, but didn’t lead to subsequent decrease caspase-3 
activation. 
Vitamin E (a-tocopherol) is an organic fat soluble compound 
located generally in cell membranes. This dominant anti-
oxidant extinguishes superoxide anions and free hydroxyl 
radicals thereby reducing lipid peroxidation initiated by 
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Fig 2. Relative abundance of DAZL transcripts in rat testes tissue 
derived from treated rats with busulfan solvent (DMSO), Vitamin E (Vit 
E), L-carnitine and Melatonin (LM), atorvastatin and melatonin (AM), 
atorvastatin, L-carnitine, and Melatonin (ALM) compared to control 
group (busulfun treated rats).  All reactions were normalized for β-Actin 
mRNA expression. Values with superscripts “*” refers to significant 
(P<0.05) differences in relative transcript abundance of each group 
compared to control group
Table 3. Mean±SEM of relative abundance of Bcl2, Casp3, DAZL mRNA in 
treatment groups in comparison with control group
Groups Bcl2 Casp3 DAZL
DMSO 0.82±0.13 0.65±0.24 1.29±0.11
Vit E 1.67±0.20 7.68±0.74* 1.97±0.08*
AM 0.37±0.03 0.03±0.02* 1.77±0.01
LM 0.2±0.08* 0.86±0.17 1.50±0.10
ALM 0.13±0.05* 0.49±0.31* 1.29±0.01
All reactions were normalized for β-Actin mRNA expression. “*” refers 
to significant (P<0.05) differences in relative transcript abundance of each 
group compared to control group
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ROS in plasma membranes [30] and thus protects the cell 
membrane from ROS-induced damages. This antioxidant 
reduces testicular tissue damages cause by cytotoxic agents 
through increasing the expression of antioxidant related 
genes. In the male reproductive tract, the antioxidant 
property of this vitamin in inhibition of destructive effects 
of free radicals in testes [31] and sperm [32] was confirmed. 
As well as, some studies showed vitamin E is efficient in 
protecting testes from induced damage by oxidative stress 
and mitigation this damage can be achieved by vitamin E 
treatment [33]. 
It was expected high expression of Bcl2 reduces Casp3 
expression after administration of Vitamin E. But, it should be 
considered that there are at least two principal pathways 
for activating Casp3. The more ancient, which is induced by 
diverse intracellular stresses, including cytokine deprivation 
and genotoxic damage, is regulated by Bcl2 and its 
relatives. Progression through the pathway usually leads 
to the activation of Casp9 and subsequently Casp3. A 
more-recently evolved pathway is triggered when ‘death 
receptors’ on the plasma membrane engaged by cognate 
ligands of the tumour-necrosis factor (TNF) family, recruit 
Casp8 through bind the adaptor protein FAS-associated 
death domain (FADD)(also called MORT1). This pathway 
eventually increase Casp3 [10]. Therefore, high expression of 
Casp3 in vitamin E-treated rats may be due to activation of 
second mentioned pathway. 
Among the groups, Vitamin E more moderated spermato-
genesis resumption as showed in increasing DAZL gene 
expression. This study was the first study in directly 
determination of the effect of vitamin E on DAZL expression 
as a worthy candidate for male infertility that plays an 
important role in the spermatogenesis.  
However, a number of studies suggested that supplemen-
tation with oral antioxidants such as vitamin E and carnitine 
could improve the sperm quality in infertile patients which 
can certainly be through the stimulation of related gene 
expression such as DAZL.  
However, we observed lower Casp3 gene expression in 
other treatments, especially in those rats treated with both 
AM and ALM. When combination groups were compared 
to each other, it was defined that down-regulation of 
Casp3 mRNA in AM and ALM groups might be more due 
to the presence of melatonin, and on the other hand, high 
expression of this gene in LM in comparison of AM group 
and then ALM group was created by L-carnitine. This is 
consistent with Fan et al.[34] study that expressed mRNA 
and protein levels caspase-8 was increased by L-carnitine 
treatment in hepa1c1c7 mouse cancer cells. As well as, it 
was noted that despite the inhibition effect of L-carnitine 
on the activity of recombinant caspases 3 in Jurkat cells 
(a human  T lymphocyte  cells line), its long-chain fatty 
acid derivative palmitoylcarnitine increases the activity 
of all the caspases. It was suggested that reversed effect 
of palmitoylcarnitine on the inhibition of caspase activity 
by carnitine, may be regulated in part by the balance of 
palmitoylcarnitine and carnitine under physiological 
conditions [35]. 
Many studies demonstrated that melatonin has an anti-
apoptotic effect in somatic and germ cells [36-38]. Melatonin 
has been reported to be protective in male reproductive 
health, which readily crosses the blood-testes barrier 
and has a very low toxicity [39]. Studies have investigated 
the use of melatonin to relieve the side effects of 
environmental toxins and chemotherapy drugs during 
spermatogenesis [36,40]. However, few systematic studies 
have investigated whether melatonin employs a protective 
role in the psychological stress-induced impairment of 
spermatogenesis as well as the mechanisms by which 
melatonin mitigates the damage in testes.
Many studies have found that L-carnitine and its derivatives 
can optimize sperm motion parameters [41,42]. On the other 
hand, other studies failed to detect significant increases in 
sperm concentration following L-carnitine treatment [43-45]. 
The relatively small doses and short duration of treatment 
employed may be the main reason why no substantial 
increases were detected. By the large, it has be found that 
L-carnitine further improves sperm motility and chromatin 
quality via antioxidant properties, the enhanced glucose 
uptake by sperm [46], and long chain fatty acids trans-
portation across the inner membrane of the mitochondria 
for use in metabolism [47]. On the other hand, its effects 
in reducing some of the side effects of busulfan on the 
testes is lower than other used compounds [25]. This maybe 
the reason of low expression of DAZL in the L-carnitine-
contained groups in comparison the other groups.
In this study the lowest expression of Bcl2 was seen in ALM 
group. The main reason of this event can be atorvastatin. 
Atorvastatin improves the lipid profile, lipid oxidation, and 
oxidative/antioxidative status. These positive effects may 
be attributed to the antioxidant properties of statins. It has 
been suggested that statins increase apoptosis and change 
levels of Bcl2 family members (e.g., Bax increasing and Bcl2 
reduction). Several reports found that statins reduce levels 
of the anti-apoptotic protein Bcl2, and increase apoptosis 
and cell death [48-50]. Though, there is evidence that statins 
increase Bcl2 abundance which would desirable and in 
some instances reduce apoptosis and cell death [51,52]. 
Generally at high statin concentrations apoptosis is increased, 
and Bcl2 expression levels and cell viability are reduced [53]. 
The mechanisms for the statin-induced reduction of Bcl2 
protein levels have not been forthcoming. Statins reduce 
cholesterol, protein prenylation, and two isoprenoids 
FPP (farnesyl pyrophosphate) and GGPP (geranylgeranyl 
pyrophosphate but how those reductions trigger a 
weakening of the anti-apoptotic protein Bcl2 and increase 
abundance of pro-apoptotic proteins such as Bax and 
Bim is not understood. There is evidence that statins has 
7function outside of the mevalonate pathway. Statins for 
example bind to a heterodimeric glycoprotein, lymphocyte 
function-associated antigen-1 (LFA-1) which is a member 
of the β2 integrin family [54]. Directly related to the subject 
of statins, these compounds increase Bcl2 gene expression 
and protein levels, which do not involve the mevalonate 
pathway.
It can be concluded that, according to the antiapoptotic 
effects of these antioxidants, vitamin E retrieved spermato-
genesis potential of busulfan-induced infertile male 
rats better than the other antioxidants used in different 
combinations. It was approved by increasing DAZL 
gene expression, a worthy candidate for male infertility 
evaluation.
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